HDAC8 is upregulated in breast cancer, urothelial cancer, hepatocarcinoma, and acute lymphatic leukemia, and is associated with poor prognosis and low overall survival rates in neuroblastoma [25,26,27,28,29]. The gene discussed is HDAC8; the disease is neuroblastoma.